Amgen files update to Tavneos label as FDA escalates push to withdraw 

Amgen has taken steps to update its Tavneos label amid an ongoing battle with the FDA. The company filed a supplement on Wednesday that would add more information to the warning …
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks